Advances and challenges in gene therapies (part 2)
Wednesday, September 14, 2022
PLENARY
•
14-PM-PLENARY
•
2:30 PM
>
4:00 PM
•
Advances and challenges in gene therapies (part 2)
•
Apollon Auditorium
2:30 PM
•
S12L1
•
X-linked myotubular myopathy and liver dysfunction
>
A.
Ana
BUJ-BELLO (Evry, France)
3:00 PM
•
S12L2
•
Modelling and editing Duchenne Muscular Dystrophy
>
W-H.
Wolfram-Hubertus
ZIMMERMANN (Goettingen, Germany)
3:30 PM
•
S12L3
•
Application of CRISPR/Cas9 strategy for gene therapy of Myotonic Dystrophy type 1
>
G.
Germana
FALCONE (Monterotondo, Italy)
|